Please ensure Javascript is enabled for purposes of website accessibility

Ionis Pharmaceuticals Inc Takes It to the Extremes

By Brian Orelli, PhD - Jan 15, 2016 at 4:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares are moving at the whim of market sentiment.

What: Ionis Pharmaceuticals (IONS 0.18%) was down as much as 10.5% today. It seems the reason for the drop was because today isn't Thursday.

So what: It's been a rollercoaster ride for Ionis, which is trading like most other biotechs, just a little more extreme in both directions.

IONS Price Chart

IONS Price data by YCharts.

Yesterday, Ionis Pharmaceuticals went up 9.4% while the iShares Nasdaq Biotechnology ETF (IBB -1.52%) was up only 4%. Today, Ionis Pharmaceuticals ended the day down 8.4% while the ETF fell 2.5%

Now what: There's not much investors can do but laugh -- and perhaps cry -- at the gyrations, given the complete lack of fundamental changes that the biotech has been through. While the short-term stock volatility will be ruled by investors' feelings about biotech, in general, Ionis' long-term price will be determined by the outcomes of the clinical trials it's running.

Ionis Pharmaceuticals has 38 drugs in development. If many of them are proven to work -- especially the three drugs in phase 3 trials -- the value will go up no matter what the ETF does.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Ionis Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Ionis Pharmaceuticals, Inc. Stock Quote
Ionis Pharmaceuticals, Inc.
IONS
$43.96 (0.18%) $0.08
iShares Trust - iShares Nasdaq Biotechnology ETF Stock Quote
iShares Trust - iShares Nasdaq Biotechnology ETF
IBB
$128.42 (-1.52%) $-1.98

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
395%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.